Eagle Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$2.01M Buy
30,282
+8,346
+38% +$553K 0.01% 461
2024
Q2
$1.98M Buy
21,936
+11,052
+102% +$997K 0.01% 471
2024
Q1
$1.03M Buy
10,884
+7,727
+245% +$728K 0.01% 502
2023
Q4
$241K Buy
+3,157
New +$241K ﹤0.01% 541
2019
Q2
Sell
-1,602,246
Closed -$102M 646
2019
Q1
$102M Sell
1,602,246
-13,083
-0.8% -$834K 0.54% 47
2018
Q4
$82.5M Buy
1,615,329
+168,429
+12% +$8.6M 0.52% 52
2018
Q3
$84M Sell
1,446,900
-379,719
-21% -$22M 0.41% 77
2018
Q2
$88.6M Buy
1,826,619
+213,456
+13% +$10.4M 0.48% 61
2018
Q1
$75M Buy
1,613,163
+134,490
+9% +$6.25M 0.41% 80
2017
Q4
$56.3M Buy
1,478,673
+139,224
+10% +$5.3M 0.31% 106
2017
Q3
$49.1M Buy
1,339,449
+59,538
+5% +$2.18M 0.28% 127
2017
Q2
$50.4M Buy
1,279,911
+449,286
+54% +$17.7M 0.3% 114
2017
Q1
$26M Sell
830,625
-51,144
-6% -$1.6M 0.16% 188
2016
Q4
$27.5M Sell
881,769
-16,641
-2% -$520K 0.18% 164
2016
Q3
$36.1M Sell
898,410
-54,786
-6% -$2.2M 0.24% 131
2016
Q2
$31.7M Sell
953,196
-16,437
-2% -$546K 0.22% 142
2016
Q1
$28.5M Sell
969,633
-6,183
-0.6% -$182K 0.2% 159
2015
Q4
$25.7M Buy
975,816
+60,126
+7% +$1.58M 0.17% 180
2015
Q3
$21.7M Buy
915,690
+6,528
+0.7% +$155K 0.15% 201
2015
Q2
$21.6M Buy
909,162
+61,908
+7% +$1.47M 0.12% 204
2015
Q1
$20.1M Buy
847,254
+752,052
+790% +$17.9M 0.12% 220
2014
Q4
$2.02M Sell
95,202
-75,924
-44% -$1.61M 0.01% 547
2014
Q3
$2.91M Sell
171,126
-175,692
-51% -$2.99M 0.02% 526
2014
Q2
$4.96M Sell
346,818
-52,872
-13% -$756K 0.03% 457
2014
Q1
$4.94M Sell
399,690
-17,274
-4% -$213K 0.03% 482
2013
Q4
$4.57M Sell
416,964
-290,256
-41% -$3.18M 0.03% 450
2013
Q3
$8.11M Buy
707,220
+189,456
+37% +$2.17M 0.04% 401
2013
Q2
$5.8M Buy
+517,764
New +$5.8M 0.04% 426